Advertisement
ASH: Daratumumab + Pomalidomide

Allergists Affirm Safety of COVID-19 Vaccines for Most

0

All patients should be observed for 15 minutes after vaccination; staff should be trained in anaphylaxis management

Could the TB Vaccine Help Prevent COVID-19?

11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported

0

Median interval from vaccine receipt to symptom onset was 13 minutes

Un antidepresivo podría ayudar a prevenir una COVID-19 grave

Pulse Oximeter Readings May Be Inaccurate in Black Patients

0

Blacks more likely than Whites to have oxygen saturation of less than 88 percent on arterial blood gas while 92 to 96 percent on pulse oximetry

HealthDay Reports: Brazil

~14.3 Percent of U.S. Population Infected With SARS-CoV-2 by Nov. 15

0

Estimated medians of 46,910,006 SARS-CoV-2 infections, 956,174 hospitalizations, 304,915 deaths reported by mid-November

Okada Test Article

Euglycemic DKA ID’d in T2DM Patients With COVID-19

0

Five cases of euDKA identified in patients with type 2 diabetes using SGLT2 inhibitors who developed SARS-CoV-2 infection

Organized Sports May Help Boys Control Behavior

Child Physical Abuse Encounters Declined During COVID-19

0

Declines occurred during period when total volume of encounters was also lower; severity of encounters unchanged versus previous years

Mental Health Consequences of COVID-19 ID’d Across Populations

0

Health care workers have higher prevalence of insomnia; however, mental health problems seen across countries, gender

11/24 -- More U.S. Kids Swallowing Powerful Magnets After Deregulation

Los Angeles EMS Told to Not Transport Patients Deemed Likely to Die

0

L.A. County Emergency Medical Services Agency also told EMS workers to give less oxygen to patients

U.S. Health Care Spending Increased 4.6 Percent in 2019

0

Growth rate similar to that experienced in 2018 and consistent with growth rate since 2016

ASH: Daratumumab + Pomalidomide

mRNA-1273 Vaccine Highly Effective for Preventing COVID-19

0

Published data on Moderna vaccine show severe COVID-19 in 30 individuals -- all in the placebo group -- in trial of 30,420 participants